d509 hackensack innovation assessment worksheet (3)
docx
keyboard_arrow_up
School
Western Governors University *
*We aren’t endorsed by this school
Course
D509
Subject
Management
Date
Jan 9, 2024
Type
docx
Pages
8
Uploaded by ConstableComputerFerret9609
Hackensack Innovation Assessment Worksheet (Assignment 2)
Instructions:
Complete a brief analysis that includes a description of the Hackensack innovation, a determination of the type of innovation, and Herzlinger’s six-factor analysis to assist in assessing
the potential impact of the Hackensack innovation using Miller’s Impact Assessment Framework.
1.
Describe the innovation.
Describe the innovation and the problem it addresses.
The Hackensack innovation is the introduction of an integrated Bluetooth devises such as a blood pressure cuff, pulse oximeter, glucometer and 4G tablet that can be used by outpatients to monitor their disease. The goal behind this innovation was to reduce re-admission rates and to improve the patient’s quality of life.
2.
Determine the type of innovation.
Determine and justify whether the innovation is sustaining or disruptive. The Merriam-Webster dictionary describes an innovation as the introduction of something new. When you take a closer look at Hackensack innovation the only new innovation would be the technology developed for the tablet device everything else used already exists in the healthcare world. After a lot of thought I believe that this innovation has both aspects of disruptive and sustaining, but has more characteristics of a sustaining innovation. I used the following reasons to back my finding up:
Improved existing technology.
Cost effectiveness of the technology
Does not create new markets.
Gathering feedback from the data obtained aided the ACO in expanding the use of technology platforms.
Use all available channels to obtain feedback from customers.
Reduced overhead costs by reducing hospital readmission.
3.
Analyze the innovation.
Complete a six-factor analysis of the innovation (based on Herzlinger’s “Innovating in Health Care—Framework”).
Structure Who is a friend? Who is a foe? How much power do they have to help or hurt the new venture?
When it comes to helping an organization both friend and foe and contribute to the well being of that organization. A friend can help strengthen an organization whereas a foe can help tear down an organization. For me I feel that foes have more power than friends. Friends will only strengthen an organization but foes if significant can tear an organization down.
The staff of the organization could be a friend or foe. If they do the following, they can benefit the program:
Educate the patients on how to use the new devise.
When they receive alerts from the devises to follow up in a timely manner.
Help set up appointments and make sure the patients are attending those appointments.
However, if they let something fall through a crack or do not follow up in a timely manner, they can be harmful.
The patients also have the ability to be friend or foe. They are friend if they do the following:
Adhere to the program and follow instructions
Are diligent at recording data
However, if they do not do the above, they are a hindrance to the program.
Physicians can also be friend or foe.
If the physician supports the introduction and is proactive with encouraging the patient to try, they can
be very beneficial. However, if they are against the use of the devises, they will not encourage their patients to try.
Verizon would be considered a friend as they will fund the program for the next 1 year (Hackensack Alliance Accountable Care Organization, 2014).
Other foes could also include:
Insurance if they do not approve the cost of using the devise. (Future concern)
Connectivity concerns or Bluetooth outage/Wi Fi issues.
Financing How is the innovation reimbursed? Does the innovation use appropriate sources for According to the case study the program was funded in the following ways:
Health Recovery Solutions (HRS) funded the
financing? What are those sources?
pilot program
Verizon provided a grant for the first year of tablet use once the grant from HRS ended.
My question is what do they do when all of this runs out how is the cost going to be covered then?
I understand that if it prevents one patient from readmission that it “saves money” but who is going to
be responsible for the cost of the tablets and accessories in the future. Is it something that the hospital will cover to prevent readmission or is it something that will need to be covered by the patient’s insurance. Public Policy How relevant is each variable in directing public policy for the problem the innovation addresses? Examples of variables include political environment, stakeholder dynamics, regulatory and legislative process dynamics, and biases of key policy makers.
Technology is regulated by the U.S. Government’s Food and Drug Administration (FDA) (Herzlinger, 2013). Nowhere in the case study did it state if this technology had been approved. As this innovation is still at the pilot stage it still has many obstacles to overcome. It will need to be approved by the FDA for starters. The stakeholders of this innovation need to take into consideration how this will be funded by insurance when all other avenues of finance dry up. The big problem with this would be your government run insurance companies and the fact that they are not willing to cover expensive devises. I feel that it is two early in the game for this innovation for the other two variables to factor.
Technology When is the opportune time to invest in the technology? Who are the competitors?
There is the age old saying: “Timing is everything in life.” The right time to consider adopting technology is when you have identified the why behind your business, the who
you are planning to help and the people who will drive it forward. When you look at the case study the who and why have been identified but they still do not really have who will drive it forward. They have Verizon supporting them for another year but once that it over who will support the technology moving forward who will be the driving force: insurance companies, hospitals, patients. Once this is all in place then it would be a good time to invest. In the healthcare industry anyone and everyone is a competitor as there is a constant race to have the best technology or to produce the best technology.
Consumers How does the innovation address consumers’ increased sense of empowerment and lack of In the case study the consumer are people with Chronic heart failure. The innovation will help these patients to take control of their disease helping to
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
leisure time?
provide them with a sense of empowerment. By being able to monitor their health data and input it into the tablet they are able to receive feedback from nurse navigators and don’t have to worry about having to go and see a doctor for feedback allowing them more time at home and less time spent at the hospital.
Accountability How does the innovation meet the various demands for accountability?
Accountability is aways in the hands of the patient. There is only so much medical staff can do the rest is up to you as a patient. If the patients do not comply with the teaching provided from the nurse navigators, then the data collection will be unsuccessful. It will be up to the patient to input their blood pressure values, glucose, weight and pulse oximeter data into the tablet.
4.
Assess the impact. Use Miller’s Impact Assessment Framework (IAF), described in the IAF guide, to complete a summarized assessment of the Hackensack Alliance case.
First, complete the “scan” step of an impact assessment for the technology innovation (see the “Methodology for Applying the Impact Assessment Framework” section in the IAF guide). Scan all eight dimensions to ensure you have a broad perspective on dimensions that are not normally taken into consideration. As you scan the innovation, consider which outcomes apply to your innovation. Use the table below to record the results of your scan. You may delete the outcomes that do not apply. Include your questions or statements in the “Outcomes” column. Every dimension should have at least one outcome.
Second, select two of the dimensions that you think are most impacted by the innovation. Evaluate and justify how these two dimensions are most impacted based on your analysis.
Document your findings in the “Dimensions Impacted by Innovation” column in the table
below.
An example is provided in the first row of the table.
Dimension
Outcomes
Dimensions Impacted by Innovation
Example:
A. Individual
Example:
A1. Experience of health – How will Hackensack improve the patient experience?
A2. Health across settings
A3. Privacy
A4. Empowerment
A5. Behavior
Example:
This dimension has the potential to be highly impacted due to __.
A. Individual
A1. Experience of health – Will the patient perceive the 4G tablet and This dimension has the potential to be highly impacted due to the
accessories helpful and do they feel that Hackensack is responsive to their needs (Miller).
A2. Health across settings
A3. Privacy
A4. Empowerment – Will this help the patient take control of their disease?
A5. Behavior
ACO patients that used the tablet post hospital discharge having a 5.5% 30-day readmission rate, compared to a 28% readmission rate for the trial group (
Hackensack Alliance Accountable Care Organization).
This dimension has the potential to be highly impacted due to the education provided to the patients upon discharge. The nurse navigators will walk the patients through the easy-to-use tablet and instruct them on when to record data, empowering them to take control of their congestive heart failure.
B. Health Services
B1. Patient safety and quality of care –
how will Hackensack safely identify patients at risk and get them the care that they need?
B2. Advancing the standard of care
B3. Care efficiency
B4. Provider experience of care
B5. Health services model – What changes will Hackensack make to the home health model?
This dimension has the potential to be highly impacted due to the reduction in hospital readmissions. It will also help the
patients spend more time at home and less time at a doctor’s office as if ab problem arises a nurse navigator will be in contact and advise on next steps.
This dimension has the potential to be highly impacted due to the patient taking responsibility of their own care, this could reduce the need for a home health nurse coming to the house for visits, with the Hackensack tablet the patients is able to track data and even keep track of one’s medicine.
C. Community
C1. Access to health services – With the introduction of this technology can Hackensack improve a certain patients demographics access to health services? C2. Public health
C3. Population health management
C4. Community engagement – Hackensack with the introduction of this technology only targets a certain demographic but it is stated in the case study that there are plans to use it to monitor other disease processes.
D. Operations
D1. Capacity and utilization – The current pilot program used only 30 patients; will it be able to accommodate more? How many patients can they have on a platform at a given time?
D2. Facilities and fixed assets
D3. Logistics and supply chain
D4. Productivity and optimization
E. Organization and Workforce
E1. Leadership and culture
E2. Organizational structure
E3. Personnel – With the growth of the
Hackensack project will they need to hire more nurse navigators and IT personal to meet the need of more patients?
E4. Human resources
E5. Performance
F. Strategy and Finance
F1. Revenue
F2. Operating costs – Verizon has provided a grant to cover 1 year of use,
how will Hackensack cover the costs after this year?
F3. Investment and debt
F4. Financial performance
F5. Business strategy – How can Hackensack market this 4G tablet in a way that differentiates itself against other local health systems?
F6. Innovation strategy
G. Risk Management
G1. Clinical
G2. Regulatory
G3. Financial
G4. Operational – How hard will it be after the given year to deploy more devises to cover more patients and what will the costs be to add these devices?
G5. Ethical
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
H. Information Management
H1. Information – How will the use of the information gained be used to understand overall trends in that area?
H2. Systems
5.
Assess success. Provide a brief assessment with a justification of how successful you believe the innovation is or will be. Document any outside sources that inform your answer. I believe that this project will be very successful when they get if up and running. A major concern that I have is what happens after the Verizon grant is done how will the project be funded? According to Tenovi remote patient monitoring (RPM) for chronic disease management is the way forward. RPM leads to decreased ER visits and prevents readmissions.
The article on the Tenovi website goes on to state that patients using RPM for chronic disease management are much less likely to be admitted into hospital, use emergency rooms, and require complicated procedures which significantly reduce healthcare costs (Ian, 2023). With RPM patients are having to take control of their diseases in the long run this is making them understand their conditions better and forcing them to step up and make changes. So not only are health care costs being reduced but patients are becoming more aware of what is wrong and
what needs to be done to improve their conditions.
References:
Hackensack Alliance Accountable Care Organization. (2014, March).
Use case study: Remote patient monitoring for chronic disease
. Healthcare Information and Management Systems
Society (HIMSS), 1–7. https://wgu.yourlearningportal.com/wgu/resources/courses/wgu_courses/hcm/mhl/
C980_MHL5110_innovation_solutions/resources/hackensack_use_case_study.pdf
Herzlinger, R. E. (2013, July).
Innovating in health care—Framework
. Harvard Business School Background Note, 314–017. https://wgu.yourlearningportal.com/wgu/resources/courses/wgu_courses/hcm/mhl/
C980_MHL5110_innovation_solutions/resources/
herzlinger_innovative_ihc_framework.pdf
Ian. (2023, September 26). The role of remote patient monitoring in optimizing chronic disease management
. Tenovi. https://tenovi.com/remote-patient-monitoring-chronic-disease-
management/
Miller, C. (n.d.)
Impact assessment framework
. Master Health Leadership Program. Western Governors University, 1–33. https://wgu.yourlearningportal.com/wgu/resources/courses/wgu_courses/hcm/mhl/
C980_MHL5110_innovation_solutions/resources/impact_assessment_framework.pdf
Pisano, G. P. (2014, November 2). In Defense of Routine Innovation
. Harvard Business Review. https://hbr.org/2014/06/in-defense-of-routine-innovation
Related Documents
Recommended textbooks for you

Management, Loose-Leaf Version
Management
ISBN:9781305969308
Author:Richard L. Daft
Publisher:South-Western College Pub
Recommended textbooks for you
- Management, Loose-Leaf VersionManagementISBN:9781305969308Author:Richard L. DaftPublisher:South-Western College Pub

Management, Loose-Leaf Version
Management
ISBN:9781305969308
Author:Richard L. Daft
Publisher:South-Western College Pub